Symbols / BRTX Stock $0.17 -7.52% BioRestorative Therapies, Inc.

Healthcare • Biotechnology • United States • NCM
BRTX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index
Sector Healthcare
Industry Biotechnology
CEO
Exch · Country NCM · United States
Market Cap 4.33M
Enterprise Value
Income
Sales
FCF (ttm)
Book/sh
Cash/sh
Employees
Insider 10d
IPO
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout
P/E
Forward P/E
PEG
P/S
P/B
P/C
EV/EBITDA
EV/Sales
Quick Ratio
Current Ratio
Debt/Eq
LT Debt/Eq
EPS (ttm)
EPS next Y
EPS Growth
Revenue Growth
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next)
Earnings (prior)
ROA
ROE
ROIC
Gross Margin
Oper. Margin
Profit Margin
Shs Outstand
Shs Float
Insider Own
Instit Own
Short Float
Short Ratio
Short Interest
52W High
vs 52W High
52W Low
vs 52W Low
Beta
Impl. Vol.
Rel Volume
Avg Volume
Volume
Target (mean)
Tgt Median
Tgt Low
Tgt High
# Analysts
Recom
Prev Close $0.18
Price $0.17
Change -7.52%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified FCF or EPS-based estimate
Ratings
Current target
Low
High
Mean
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.36
-10.30%
0.40
+175.03%
0.15
+21.70%
0.12
Operating Revenue
0.36
-10.30%
0.40
+175.03%
0.15
+21.70%
0.12
Cost Of Revenue
0.02
-15.06%
0.03
0.00
Reconciled Cost Of Revenue
0.02
-15.06%
0.03
0.00
Gross Profit
0.34
-9.94%
0.37
+155.78%
0.15
Operating Expense
15.98
+33.99%
11.93
-21.95%
15.28
-19.49%
18.98
Research And Development
10.09
+50.51%
6.71
+66.24%
4.03
+14.84%
3.51
Selling General And Administration
5.89
+12.78%
5.22
-53.93%
11.33
-27.27%
15.58
Selling And Marketing Expense
General And Administrative Expense
5.89
+12.78%
5.22
-53.93%
11.33
-27.27%
15.58
Other Gand A
5.89
+12.78%
5.22
-53.93%
11.33
-27.27%
15.58
Other Operating Expenses
-0.08
+24.60%
-0.11
Total Expenses
16.01
+33.88%
11.96
-21.77%
15.28
-19.49%
18.98
Operating Income
-15.65
-35.41%
-11.56
+23.66%
-15.14
+19.75%
-18.86
Total Operating Income As Reported
-15.65
-35.41%
-11.56
+24.08%
-15.22
+19.78%
-18.97
EBITDA
-15.44
-35.82%
-11.37
+24.08%
-14.97
+20.12%
-18.74
Normalized EBITDA
-16.56
-25.68%
-13.18
+30.55%
-18.97
+21.83%
-24.27
Reconciled Depreciation
0.21
+11.07%
0.19
+14.07%
0.17
+37.49%
0.12
EBIT
-15.65
-35.41%
-11.56
+23.66%
-15.14
+19.75%
-18.86
Total Unusual Items
1.12
-38.00%
1.81
-54.75%
4.00
-27.61%
5.52
Total Unusual Items Excluding Goodwill
1.12
-38.00%
1.81
-54.75%
4.00
-27.61%
5.52
Special Income Charges
0.00
-100.00%
0.25
Other Special Charges
-0.25
Restructuring And Mergern Acquisition
Net Income
-14.24
-58.61%
-8.98
+13.81%
-10.42
+21.21%
-13.22
Pretax Income
-14.24
-58.61%
-8.98
+13.81%
-10.42
+21.21%
-13.22
Net Non Operating Interest Income Expense
0.27
-56.79%
0.62
+11.55%
0.55
+4640.71%
0.01
Interest Expense Non Operating
Net Interest Income
0.27
-56.79%
0.62
+11.55%
0.55
+4640.71%
0.01
Interest Expense
Interest Income Non Operating
0.27
-56.79%
0.62
+11.55%
0.55
+4640.71%
0.01
Interest Income
0.27
-56.79%
0.62
+11.55%
0.55
+4640.71%
0.01
Other Income Expense
1.14
-41.88%
1.96
-52.98%
4.17
-25.97%
5.63
Other Non Operating Income Expenses
0.02
-88.43%
0.15
-11.09%
0.17
+58.43%
0.11
Gain On Sale Of Security
1.12
-38.00%
1.81
-54.75%
4.00
-24.18%
5.27
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-14.24
-58.61%
-8.98
+13.81%
-10.42
+21.21%
-13.22
Net Income From Continuing Operation Net Minority Interest
-14.24
-58.61%
-8.98
+13.81%
-10.42
+21.21%
-13.22
Net Income From Continuing And Discontinued Operation
-14.24
-58.61%
-8.98
+13.81%
-10.42
+21.21%
-13.22
Net Income Continuous Operations
-14.24
-58.61%
-8.98
+13.81%
-10.42
+21.21%
-13.22
Normalized Income
-15.36
-42.41%
-10.79
+25.16%
-14.42
+23.10%
-18.74
Net Income Common Stockholders
-14.24
-58.61%
-8.98
+13.81%
-10.42
+21.21%
-13.22
Diluted EPS
-1.58
-36.21%
-1.16
+53.04%
-2.47
+32.33%
-3.65
Basic EPS
-1.58
-36.21%
-1.16
+53.04%
-2.47
+32.33%
-3.65
Basic Average Shares
8.99
+15.83%
7.76
+84.05%
4.22
+16.60%
3.62
Diluted Average Shares
8.99
+15.83%
7.76
+84.05%
4.22
+16.60%
3.62
Diluted NI Availto Com Stockholders
-14.24
-58.61%
-8.98
+13.81%
-10.42
+21.21%
-13.22
Total Other Finance Cost
-0.01
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
4.08
-66.78%
12.28
-2.63%
12.61
-23.26%
16.43
Current Assets
3.14
-71.85%
11.14
-2.16%
11.39
-24.71%
15.13
Cash Cash Equivalents And Short Term Investments
2.95
-72.49%
10.73
-3.01%
11.07
-24.97%
14.75
Cash And Cash Equivalents
1.51
+175.82%
0.55
-38.05%
0.88
-48.40%
1.71
Cash Financial
Other Short Term Investments
1.44
-85.84%
10.18
+0.03%
10.18
-21.89%
13.04
Receivables
0.02
-91.77%
0.19
+876.17%
0.02
+20.63%
0.02
Accounts Receivable
0.02
-91.77%
0.19
+876.17%
0.02
+20.63%
0.02
Prepaid Assets
Other Current Assets
0.17
-24.54%
0.22
-26.87%
0.31
-15.93%
0.36
Total Non Current Assets
0.94
-16.98%
1.14
-7.01%
1.22
-6.51%
1.31
Net PPE
0.36
-1.15%
0.36
-28.49%
0.51
+0.94%
0.50
Gross PPE
1.59
+7.87%
1.47
-2.98%
1.52
+5.61%
1.44
Accumulated Depreciation
-1.23
-10.82%
-1.11
-9.81%
-1.01
-8.12%
-0.94
Buildings And Improvements
0.15
-37.36%
0.24
Machinery Furniture Equipment
0.28
+0.00%
0.28
+0.00%
0.28
+7.18%
0.26
Construction In Progress
0.06
0.00
Other Properties
0.91
+6.09%
0.85
-5.04%
0.90
+51.06%
0.59
Leases
0.34
+0.00%
0.34
+0.00%
0.34
+0.00%
0.34
Goodwill And Other Intangible Assets
0.53
-14.38%
0.62
-12.58%
0.71
-11.17%
0.80
Other Intangible Assets
0.53
-14.38%
0.62
-12.58%
0.71
-11.17%
0.80
Non Current Deferred Assets
0.05
-66.50%
0.15
0.00
Total Liabilities Net Minority Interest
3.72
-0.68%
3.75
+43.76%
2.61
-57.57%
6.14
Current Liabilities
3.72
-0.68%
3.75
+43.76%
2.61
-56.41%
5.98
Payables And Accrued Expenses
1.61
+207.52%
0.52
-41.90%
0.90
+199.39%
0.30
Payables
1.48
+191.92%
0.51
+168.52%
0.19
+10.82%
0.17
Accounts Payable
1.34
+177.70%
0.48
+155.07%
0.19
+10.82%
0.17
Other Payable
0.14
+461.40%
0.03
Current Accrued Expenses
0.13
+736.49%
0.01
-97.89%
0.71
+447.15%
0.13
Pensionand Other Post Retirement Benefit Plans Current
0.71
+1.35%
0.70
Current Debt And Capital Lease Obligation
0.16
+16.50%
0.14
Current Debt
Other Current Borrowings
Current Capital Lease Obligation
0.00
-100.00%
0.16
+16.50%
0.14
Other Current Liabilities
1.40
-44.49%
2.52
+63.27%
1.54
-72.14%
5.54
Total Non Current Liabilities Net Minority Interest
0.00
0.00
0.00
-100.00%
0.16
Long Term Debt And Capital Lease Obligation
0.16
Long Term Debt
Long Term Capital Lease Obligation
0.00
-100.00%
0.16
Stockholders Equity
0.36
-95.82%
8.53
-14.72%
10.00
-2.78%
10.29
Common Stock Equity
0.34
-95.98%
8.52
-14.74%
9.99
-2.77%
10.28
Capital Stock
0.01
+1.33%
0.01
+1.53%
0.01
-7.06%
0.02
Common Stock
0.00
+28.18%
0.00
+46.92%
0.00
+27.64%
0.00
Preferred Stock
0.01
+0.00%
0.01
+0.00%
0.01
-7.90%
0.02
Share Issued
8.88
+28.27%
6.92
+47.02%
4.71
+27.98%
3.68
Ordinary Shares Number
8.88
+28.27%
6.92
+47.02%
4.71
+27.98%
3.68
Additional Paid In Capital
170.26
+3.70%
164.20
+4.79%
156.69
+6.91%
146.56
Retained Earnings
-169.92
-9.15%
-155.68
-6.12%
-146.70
-7.64%
-136.28
Total Equity Gross Minority Interest
0.36
-95.82%
8.53
-14.72%
10.00
-2.78%
10.29
Total Capitalization
0.36
-95.82%
8.53
-14.72%
10.00
-2.78%
10.29
Working Capital
-0.59
-107.92%
7.40
-15.80%
8.78
-3.97%
9.15
Invested Capital
0.34
-95.98%
8.52
-14.74%
9.99
-2.77%
10.28
Total Debt
0.00
-100.00%
0.16
-46.19%
0.30
Capital Lease Obligations
0.00
-100.00%
0.16
-46.19%
0.30
Net Tangible Assets
-0.18
-102.24%
7.91
-14.89%
9.29
-2.07%
9.49
Tangible Book Value
-0.19
-102.43%
7.89
-14.91%
9.28
-2.06%
9.47
Preferred Shares Number
1.40
-9.40%
1.54
+10.37%
1.40
-7.90%
1.52
Preferred Stock Equity
0.01
+0.00%
0.01
+0.00%
0.01
-7.90%
0.02
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-10.79
-31.09%
-8.23
-27.99%
-6.43
-8.75%
-5.91
Cash Flow From Continuing Operating Activities
-10.79
-31.09%
-8.23
-27.99%
-6.43
-8.75%
-5.91
Net Income From Continuing Operations
-14.24
-58.61%
-8.98
+13.81%
-10.42
+21.21%
-13.22
Depreciation Amortization Depletion
0.21
+11.07%
0.19
+14.07%
0.17
+37.49%
0.12
Depreciation
0.12
+21.07%
0.10
+30.69%
0.08
+80.02%
0.04
Amortization Cash Flow
0.09
+0.00%
0.09
+0.00%
0.09
+14.57%
0.08
Depreciation And Amortization
0.21
+11.07%
0.19
+14.07%
0.17
+37.49%
0.12
Amortization Of Intangibles
0.09
+0.00%
0.09
+0.00%
0.09
+14.57%
0.08
Other Non Cash Items
0.15
+67.69%
0.09
+200.48%
-0.09
Stock Based Compensation
3.33
+18.24%
2.81
-63.86%
7.78
-38.29%
12.61
Operating Gains Losses
-1.39
+42.78%
-2.43
+46.73%
-4.57
+14.61%
-5.35
Gain Loss On Investment Securities
-1.39
+42.78%
-2.43
+46.73%
-4.57
+14.61%
-5.35
Unrealized Gain Loss On Investment Securities
-0.03
Change In Working Capital
1.31
+4470.12%
0.03
-94.44%
0.52
+3543.42%
0.01
Change In Receivables
0.17
+202.25%
-0.17
-5024.24%
-0.00
+70.00%
-0.01
Changes In Account Receivables
0.17
+202.25%
-0.17
-5024.24%
-0.00
+70.00%
-0.01
Change In Prepaid Assets
0.10
+202.97%
0.03
-41.94%
0.06
-20.86%
0.07
Change In Payables And Accrued Expense
1.03
+216.96%
0.33
-45.60%
0.60
+421.03%
0.12
Change In Accrued Expense
0.20
+495.39%
0.03
-94.36%
0.58
+11974.56%
-0.00
Change In Payable
0.84
+185.86%
0.29
+1488.58%
0.02
-84.60%
0.12
Change In Account Payable
0.84
+185.86%
0.29
+1488.58%
0.02
-84.60%
0.12
Change In Other Current Liabilities
0.00
+100.00%
-0.16
-16.50%
-0.14
+14.59%
-0.16
Investing Cash Flow
8.90
+1629.25%
0.51
-84.18%
3.25
+124.27%
-13.40
Cash Flow From Continuing Investing Activities
8.90
+1629.25%
0.51
-84.18%
3.25
+124.27%
-13.40
Net PPE Purchase And Sale
-0.12
-9.30%
-0.11
+37.92%
-0.17
+35.51%
-0.27
Purchase Of PPE
-0.12
-9.30%
-0.11
+37.92%
-0.17
+35.51%
-0.27
Capital Expenditure
-0.12
-9.30%
-0.11
+37.92%
-0.17
+61.15%
-0.44
Net Investment Purchase And Sale
9.01
+1352.11%
0.62
-81.87%
3.42
+126.41%
-12.96
Purchase Of Investment
-2.68
+87.17%
-20.89
-19.08%
-17.54
+21.87%
-22.45
Sale Of Investment
11.69
-45.64%
21.51
+2.60%
20.96
+120.86%
9.49
Net Intangibles Purchase And Sale
0.00
+100.00%
-0.17
Purchase Of Intangibles
0.00
+100.00%
-0.17
Financing Cash Flow
2.85
-61.31%
7.38
+214.18%
2.35
0.00
Cash Flow From Continuing Financing Activities
2.85
-61.31%
7.38
+214.18%
2.35
0.00
Net Issuance Payments Of Debt
0.00
Issuance Of Debt
0.00
Long Term Debt Issuance
0.00
Net Long Term Debt Issuance
0.00
Net Common Stock Issuance
3.10
0.00
-100.00%
2.35
0.00
Proceeds From Stock Option Exercised
0.04
-99.45%
7.53
0.00
Net Other Financing Charges
-0.28
-90.07%
-0.15
Changes In Cash
0.96
+386.28%
-0.34
+59.43%
-0.83
+95.71%
-19.31
Beginning Cash Position
0.55
-38.05%
0.88
-48.40%
1.71
-91.85%
21.03
End Cash Position
1.51
+175.82%
0.55
-38.05%
0.88
-48.40%
1.71
Free Cash Flow
-10.91
-30.81%
-8.34
-26.29%
-6.60
-3.90%
-6.35
Interest Paid Supplemental Data
0.00
0.00
0.00
0.00
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Change In Interest Payable
Common Stock Issuance
3.10
0.00
-100.00%
2.35
0.00
Issuance Of Capital Stock
3.10
0.00
-100.00%
2.35
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category